Literature DB >> 3312019

Epidemiology of hepatitis A and B.

G J Papaevangelou1.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3312019     DOI： 10.1007/BF01644116

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  23 in total

1.  Infectious hepatitis at Fort Yukon, Alaska-report of an outbreak, 1960-1961.

Authors:  J E MAYNARD
Journal:  Am J Public Health Nations Health       Date:  1963-01

2.  Localization of hepatitis A antigen in marmoset organs during acute infection with hepatitis A virus.

Authors:  L R Mathiesen; J Drucker; D Lorenz; J A Wagner; R J Gerety; R H Purcell
Journal:  J Infect Dis       Date:  1978-09       Impact factor: 5.226

3.  Controversies in immunization against hepatitis B.

Authors:  A J Zuckerman
Journal:  Hepatology       Date:  1985 Nov-Dec       Impact factor: 17.425

4.  Diagnostic value of anti-HBc IgM in high HBV prevalence areas.

Authors:  G Papaevangelou; A Roumeliotou-Karayannis; N Tassopoulos; P Stathopoulou
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

5.  How often does chronic liver disease follow acute hepatitis B in adults?

Authors:  A Roumeliotou-Karayannis; N Tassopoulos; S C Richardson; P Kalafatas; G Papaevangelou
Journal:  Infection       Date:  1985 Jul-Aug       Impact factor: 3.553

6.  Etiology of fulminant viral hepatitis in Greece.

Authors:  G Papaevangelou; N Tassopoulos; A Roumeliotou-Karayannis; C Richardson
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

7.  Double infections with hepatitis A and B viruses.

Authors:  N Tassopoulos; G Papaevangelou; A Roumeliotou-Karayannis; P Kalafatas; R Engle; J Gerin; R H Purcell
Journal:  Liver       Date:  1985-12

8.  Relapsing viral hepatitis type A.

Authors:  I M Jacobson; B J Nath; J L Dienstag
Journal:  J Med Virol       Date:  1985-06       Impact factor: 2.327

9.  Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions.

Authors:  F Deinhardt; A W Holmes; R B Capps; H Popper
Journal:  J Exp Med       Date:  1967-04-01       Impact factor: 14.307

10.  Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults.

Authors:  N C Tassopoulos; G J Papaevangelou; M H Sjogren; A Roumeliotou-Karayannis; J L Gerin; R H Purcell
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682
View more
  6 in total

1.  Seroprevalence of hepatitis B and C in subjects admitted to a cardiology clinics in Turkey.

Authors:  O Ozdemir; K Arda; M Soylu; O Alyan; A D Demir; E Kütük
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  Prevalence of hepatitis A, B, and C markers in school children of a rural area of Crete, Greece.

Authors:  C Lionis; E Frangoulis; M Koulentakis; E Biziagos; E Kouroumalis
Journal:  Eur J Epidemiol       Date:  1997-06       Impact factor: 8.082

Review 3.  Epidemiology of chronic viral hepatitis in the Mediterranean area: present status and trends.

Authors:  G B Gaeta; G Giusti
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

4.  Liver cancer in Asian migrants to the United States and their descendants.

Authors:  K A Rosenblatt; N S Weiss; S M Schwartz
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

5.  Considerations on the current universal vaccination policy against hepatitis A in Greece after recent outbreaks.

Authors:  Kassiani Mellou; Theologia Sideroglou; Vassiliki Papaevangelou; Anna Katsiaflaka; Nikolaos Bitsolas; Eleni Verykouki; Eleni Triantafillou; Agoritsa Baka; Theano Georgakopoulou; Christos Hadjichristodoulou
Journal:  PLoS One       Date:  2015-01-15       Impact factor: 3.240

6.  Epidemiology of hepatitis A in Greece in the last decade: management of reported cases and outbreaks and lessons learned.

Authors:  K Mellou; A Chrysostomou; T Sideroglou; M Kyritsi; T Georgakopoulou; S Tsiodras; C Hadjichristodoulou
Journal:  Epidemiol Infect       Date:  2020-02-13       Impact factor: 2.451
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.